Young C. Kim

Roosevelt Drive
Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications

Encephalitic Alphaviruses: Epidemiology, Pathogenesis and Vaccine Development.

Encephalitic Alphaviruses: Epidemiology, Pathogenesis and Vaccine Development.

Journal: Vaccines
Published: June 07, 2026

Persistence of immune responses 5 years after vaccination with a single dose of typhoid conjugate vaccine (TCV) in Nepalese children.

Persistence of immune responses 5 years after vaccination with a single dose of typhoid conjugate vaccine (TCV) in Nepalese children.

Journal: Vaccine
Published: April 27, 2026

Correction: Leveraging paired serology to estimate the incidence of typhoidal Salmonella infection in the STRATAA study.

Correction: Leveraging paired serology to estimate the incidence of typhoidal Salmonella infection in the STRATAA study.

Journal: PLoS neglected tropical diseases
Published: April 15, 2026

8-year vaccine protection following a single dose of Vi-tetanus toxoid conjugate vaccine in children in Nepal (TyVOID): a prospective cohort follow-up study of the TyVAC Nepal randomised controlled trial.

8-year vaccine protection following a single dose of Vi-tetanus toxoid conjugate vaccine in children in Nepal (TyVOID): a prospective cohort follow-up study of the TyVAC Nepal randomised controlled trial.

Journal: The Lancet. Global health
Published: March 05, 2026

Advances in Alphavirus and Flavivirus Research II.

Advances in Alphavirus and Flavivirus Research II.

Journal: Viruses
Published: February 24, 2026

Impact of dosing interval on immunogenicity following a heterologous typhoid conjugate vaccine booster in Nepalese children: An observational study.

Impact of dosing interval on immunogenicity following a heterologous typhoid conjugate vaccine booster in Nepalese children: An observational study.

Journal: The Journal of infection
Published: February 12, 2026

Phase II multicentre double-blind randomised controlled trial of a Bivalent VaccInation against Salmonella Typhi and Paratyphi A (BiVISTA) using a controlled human infection model of paratyphoid A infection: study protocol.

Phase II multicentre double-blind randomised controlled trial of a Bivalent VaccInation against Salmonella Typhi and Paratyphi A (BiVISTA) using a controlled human infection model of paratyphoid A infection: study protocol.

Journal: BMJ open
Published: January 27, 2026

Safety, Efficacy, and Immunogenicity of a Salmonella Paratyphi A Vaccine.

Safety, Efficacy, and Immunogenicity of a Salmonella Paratyphi A Vaccine.

Journal: The New England journal of medicine
Published: October 29, 2025

Structural and immunogenic characterisation of ChAdOx1 Chik-derived Chikungunya VLPs supports a mechanistic rationale for vaccine-induced protection.

Structural and immunogenic characterisation of ChAdOx1 Chik-derived Chikungunya VLPs supports a mechanistic rationale for vaccine-induced protection.

Journal: Npj viruses
Published: August 06, 2025

Recent Advances in Vaccine Development for Flaviviruses and Alphaviruses.

Recent Advances in Vaccine Development for Flaviviruses and Alphaviruses.

Journal: Vaccines
Published: July 16, 2025

An adenoviral-vectored vaccine protects mice against aerosol challenge with Yersinia pestis.

An adenoviral-vectored vaccine protects mice against aerosol challenge with Yersinia pestis.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 25, 2025

Author Correction: Immunogenic recombinant Mayaro virus-like particles present natively assembled glycoprotein.

Author Correction: Immunogenic recombinant Mayaro virus-like particles present natively assembled glycoprotein.

Journal: NPJ vaccines
Published: April 19, 2025
Showing 1-12 of 46

Last Updated: 09/26/2026